420
Views
8
CrossRef citations to date
0
Altmetric
Drug Profile

Umeclidinium bromide + vilanterol for the treatment of chronic obstructive pulmonary disease

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2016) Treatment options for moderate-to-very severe chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 17:7, pages 977-988.
Read now
Mario Cazzola, Paola Rogliani, Josuel Ora & Maria Gabriella Matera. (2015) Olodaterol + tiotropium bromide for the treatment of chronic obstructive pulmonary disease. Expert Review of Clinical Pharmacology 8:5, pages 529-539.
Read now

Articles from other publishers (6)

Chin Kook Rhee, Hajime Yoshisue & Rahul Lad. (2019) Fixed-Dose Combinations of Long-Acting Bronchodilators for the Management of COPD: Global and Asian Perspectives. Advances in Therapy 36:3, pages 495-519.
Crossref
Mario Cazzola, Luigino Calzetta, Ermanno Puxeddu, Josuel Ora, Francesco Facciolo, Paola Rogliani & Maria Gabriella Matera. (2016) Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells. Respiratory Research 17:1.
Crossref
Maria Gabriella Matera & Mario Cazzola. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 41 62 .
Mario Cazzola & Maria Gabriella Matera. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 117 129 .
Mario Cazzola, Luigino Calzetta, Josuel Ora, Ermanno Puxeddu, Paola Rogliani & Maria Gabriella Matera. (2015) Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside. Respiratory Medicine 109:10, pages 1305-1311.
Crossref
Luigino Calzetta, Maria Gabriella Matera & Mario Cazzola. (2015) Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy. European Journal of Pharmacology 761, pages 168-173.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.